Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Domain Therapeutics discovers PTGER4 antagonists

April 28, 2021

Loss of cell polarity is lung cancer precursor

April 28, 2021

Onconova opens enrollment in phase I study of ON-123300 in advanced cancer

April 28, 2021

Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820

April 27, 2021

Bayer discovers BCAT1/2 ihibitors

April 27, 2021

ER-alpha antagonists and SERDs patented by Sanofi

April 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...